These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 12632163)
1. A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Chan MM; Bulinski JC; Chang KP; Fong D Parasitol Res; 2003 Mar; 89(4):266-71. PubMed ID: 12632163 [TBL] [Abstract][Full Text] [Related]
2. An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein. Rocha MN; Corrêa CM; Melo MN; Beverley SM; Martins-Filho OA; Madureira AP; Soares RP Diagn Microbiol Infect Dis; 2013 Mar; 75(3):282-91. PubMed ID: 23312610 [TBL] [Abstract][Full Text] [Related]
3. Advances and perspectives in Leishmania cell based drug-screening procedures. Sereno D; Cordeiro da Silva A; Mathieu-Daude F; Ouaissi A Parasitol Int; 2007 Mar; 56(1):3-7. PubMed ID: 17079188 [TBL] [Abstract][Full Text] [Related]
4. Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs. Pulido SA; Muñoz DL; Restrepo AM; Mesa CV; Alzate JF; Vélez ID; Robledo SM Acta Trop; 2012 Apr; 122(1):36-45. PubMed ID: 22155571 [TBL] [Abstract][Full Text] [Related]
5. Applications of recombinant Leishmania amazonensis expressing egfp or the beta-galactosidase gene for drug screening and histopathological analysis. Okuno T; Goto Y; Matsumoto Y; Otsuka H; Matsumoto Y Exp Anim; 2003 Apr; 52(2):109-18. PubMed ID: 12806885 [TBL] [Abstract][Full Text] [Related]
6. Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug. Varela M RE; Muñoz DL; Robledo SM; Kolli BK; Dutta S; Chang KP; Muskus C Exp Parasitol; 2009 Jun; 122(2):134-9. PubMed ID: 19303871 [TBL] [Abstract][Full Text] [Related]
7. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes. Muniaraj M; Sinha PK; Das P Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608 [TBL] [Abstract][Full Text] [Related]
8. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291 [TBL] [Abstract][Full Text] [Related]
9. Use of in vivo and in vitro systems to select Leishmania amazonensis expressing green fluorescent protein. Costa Sdos S; de Assis Golim M; Rossi-Bergmann B; Costa FT; Giorgio S Korean J Parasitol; 2011 Dec; 49(4):357-64. PubMed ID: 22355202 [TBL] [Abstract][Full Text] [Related]
10. Short report: fluorescent Leishmania: application to anti-leishmanial drug testing. Singh N; Dube A Am J Trop Med Hyg; 2004 Oct; 71(4):400-2. PubMed ID: 15516633 [TBL] [Abstract][Full Text] [Related]
11. Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies. Bolhassani A; Taheri T; Taslimi Y; Zamanilui S; Zahedifard F; Seyed N; Torkashvand F; Vaziri B; Rafati S Exp Parasitol; 2011 Mar; 127(3):637-45. PubMed ID: 21187086 [TBL] [Abstract][Full Text] [Related]
12. Effect of Bixa orellana against Leishmania amazonensis. García M; Monzote L; Montalvo AM; Scull R Forsch Komplementmed; 2011; 18(6):351-3. PubMed ID: 22189367 [TBL] [Abstract][Full Text] [Related]
13. Structure/antileishmanial activity relationship study of naphthoquinones and dependency of the mode of action on the substitution patterns. Ali A; Assimopoulou AN; Papageorgiou VP; Kolodziej H Planta Med; 2011 Dec; 77(18):2003-12. PubMed ID: 21800278 [TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B. Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570 [TBL] [Abstract][Full Text] [Related]
15. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice. Lang T; Goyard S; Lebastard M; Milon G Cell Microbiol; 2005 Mar; 7(3):383-92. PubMed ID: 15679841 [TBL] [Abstract][Full Text] [Related]
16. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents. Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203 [TBL] [Abstract][Full Text] [Related]
17. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham. de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075 [TBL] [Abstract][Full Text] [Related]
18. Effect of imidocarb and levamisole on the experimental infection of BALB/c mice by Leishmania (Leishmania) amazonensis. Rodrigues FH; Afonso-Cardoso SR; Gomes MA; Beletti ME; Rocha A; Guimarães AH; Candeloro I; de Souza MA Vet Parasitol; 2006 Jun; 139(1-3):37-46. PubMed ID: 16647821 [TBL] [Abstract][Full Text] [Related]
19. Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro. Kamau SW; Grimm F; Hehl AB Antimicrob Agents Chemother; 2001 Dec; 45(12):3654-6. PubMed ID: 11709363 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of four Leishmania species constitutively expressing GFP protein. A model for drug discovery and disease pathogenesis studies. Patel AP; Deacon A; Getti G Parasitology; 2014 Apr; 141(4):501-10. PubMed ID: 24252638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]